Navidea Biopharmaceuticals (NYSE: NAVB) 12.7% HIGHER; announced that results from an investigator-initiated, comparative study of Lymphoseek® (technetium Tc 99m tilmanocept) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Special Reports

BMO Capital Cuts Price Target Following United Natural Foods (UNFI) 3Q ResultsJune 9, 2015 2:23 PM Jefferies Raises Price TARGET on Dave & Buster's Entertainment (PLAY) Following EPS Beat June 9, 2015 8:47 AM Canaccord Genuity Cuts Price Target on United Natural Foods (UNFI) Following Q3 Results June 9, 2015 8:38 AM Piper Jaffray Cuts Price Target to United Natural Foods (UNFI) Following Q3 June 9, 2015 8:30 AM Jefferies Cuts Price Target Following United Natural Foods (UNFI) Q3 Results June 9, 2015 7:19 AM RBC Capital Cut Price Target on United Natural Foods (UNFI) Following 3Q Results June 9, 2015 7:03 AM